Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01509287 · ClinicalTrials.gov registry record
Metabolic Screening in Patients With Donnai-Barrow Syndrome
A clinical trial of Donnai-Barrow Syndrome, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 78
- Enrollment target
- 1
- Study location
NCT01509287 is a study of Donnai-Barrow Syndrome that has completed, run by Massachusetts General Hospital. The registered enrollment target is 78 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01509287, a study of Donnai-Barrow Syndrome, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 78 participants
- Enrollment target
- 1
- Study location
Study Summary
This study focuses on the genetics and metabolism of Donnai-Barrow Syndrome (DBS).
Conditions Studied
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2010-03 |
| Est. Completion | 2022-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01509287
The ClinicalTrials.gov registry entry for NCT01509287 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Donnai-Barrow Syndrome appearing as the primary indexed condition, and to 0 interventions.
NCT01509287 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01509287 about?
NCT01509287 is a clinical study titled "Metabolic Screening in Patients With Donnai-Barrow Syndrome". This study focuses on the genetics and metabolism of Donnai-Barrow Syndrome (DBS).
What is the current status of trial NCT01509287?
This trial is currently completed. The enrollment target is 78 participants. The study started on 2010-03. Estimated completion is 2022-06-30.
What conditions does trial NCT01509287 study?
This clinical trial studies the following conditions: Donnai-Barrow Syndrome.
Who is sponsoring clinical trial NCT01509287?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01509287 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.